Cargando…

eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma

BACKGROUND: Skin cutaneous melanoma (SKCM) is the deadliest skin cancer and has the most rapidly increasing incidences among all cancer types. Previous research elucidated that melanoma can only be successfully treated with surgical abscission in the early stage. Therefore, reliable and specific bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Fangyingnan, Waheed, Saquib, Armato, Ubaldo, Wu, Jun, Zhang, Chao, Li, Zhibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189357/ https://www.ncbi.nlm.nih.gov/pubmed/35707354 http://dx.doi.org/10.3389/fonc.2022.848346

Ejemplares similares

Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery
por: Waheed, Saquib, et al.
Publicado: (2022)

Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma
por: Tang, Diana Y. L., et al.
Publicado: (2016)

Prognostic biomarker CCR6 and its correlation with immune infiltration in cutaneous melanoma
por: Nurzat, Yeltai, et al.
Publicado: (2023)

CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
por: Zhou, Xuezhi, et al.
Publicado: (2021)

A Four-Gene-Based Prognostic Model Predicts Overall Survival in Patients With Cutaneous Melanoma
por: Tong, Xiaoxia, et al.
Publicado: (2021)

CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration
por: Li, Tianhao, et al.
Publicado: (2023)

Identification of Therapeutic Targets and Prognostic Biomarkers Among Integrin Subunits in the Skin Cutaneous Melanoma Microenvironment
por: Nurzat, Yeltai, et al.
Publicado: (2021)

Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma
por: Zeng, Furong, et al.
Publicado: (2020)

Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma
por: Dong, Xubin, et al.
Publicado: (2021)

Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Based on Cytolytic Activity in Skin Cutaneous Melanoma
por: Zhang, Haoxue, et al.
Publicado: (2022)

The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma
por: Zhao, Xiaobei, et al.
Publicado: (2019)

Over Expressed TKTL1, CIP-2A, and B-MYB Proteins in Uterine Cervix Epithelium Scrapings as Potential Risk Predictive Biomarkers in HR-HPV-Infected LSIL/ASCUS Patients
por: Chiarini, Anna, et al.
Publicado: (2019)

Mesenchymal stromal cells-exosomes: a promising cell-free therapeutic tool for wound healing and cutaneous regeneration
por: Hu, Peng, et al.
Publicado: (2019)

New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma via Comprehensive Bioinformatic Analysis and Validation
por: Zhou, Sitong, et al.
Publicado: (2021)

Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry Experience
por: Crispo, Anna, et al.
Publicado: (2021)

Development and Validation of a Novel Survival Model for Cutaneous Melanoma Based on Necroptosis-Related Genes
por: Niu, Zehao, et al.
Publicado: (2022)

Corrigendum to: ‘Mesenchymal stromal cells-exosomes: a promising cell-free therapeutic tool for wound healing and cutaneous regeneration’
por: Hu, Peng, et al.
Publicado: (2020)

Metabolic Traits in Cutaneous Melanoma
por: Neagu, Monica
Publicado: (2020)

Liver injury during durvalumab-based immunotherapy is associated with poorer patient survival: A retrospective analysis
por: Swanson, Linnea A., et al.
Publicado: (2022)

Apprising Diagnostic and Prognostic Biomarkers in Cutaneous Melanoma—Persistent Updating
por: Georgescu, Simona Roxana, et al.
Publicado: (2022)

Construction of immunotherapy-related prognostic gene signature and small molecule drug prediction for cutaneous melanoma
por: Xing, Jiahua, et al.
Publicado: (2022)

The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma
por: Takabe, Piia, et al.
Publicado: (2022)

Poor Lymphocyte Infiltration to Primary Tumors in Acral Lentiginous Melanoma and Mucosal Melanoma Compared to Cutaneous Melanoma
por: Nakamura, Yoshiyuki, et al.
Publicado: (2020)

ITGAL as a prognostic biomarker correlated with immune infiltrates in melanoma
por: Deng, TengFei, et al.
Publicado: (2023)

Translational control mechanisms in cutaneous malignant melanoma: the role of eIF2α
por: Maida, Immacolata, et al.
Publicado: (2019)

Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis
por: Yan, Junya, et al.
Publicado: (2020)

Hierarchical Clustering of Cutaneous Melanoma Based on Immunogenomic Profiling
por: Yu, Jie, et al.
Publicado: (2020)

The Dark Side of Melanin Secretion in Cutaneous Melanoma Aggressiveness
por: Cabaço, Luís C., et al.
Publicado: (2022)

Association of JAK/STAT genetic variants with cutaneous melanoma
por: Gomez, Gabriela Vilas Bôas, et al.
Publicado: (2022)

Predictive accuracy of risk prediction models for recurrence, metastasis and survival for early-stage cutaneous melanoma: a systematic review
por: Kunonga, Tafadzwa Patience, et al.
Publicado: (2023)

Exosomes and Their Bioengineering Strategies in the Cutaneous Wound Healing and Related Complications: Current Knowledge and Future Perspectives
por: Yang, Guang, et al.
Publicado: (2023)

Subphrenic Lymph Node Metastasis Predicts Poorer Prognosis for Nasopharyngeal Carcinoma Patients With Metachronous Metastasis
por: Zhang, Xue-Fang, et al.
Publicado: (2021)

Discovery and Validation of a Metastasis-Related Prognostic and Diagnostic Biomarker for Melanoma Based on Single Cell and Gene Expression Datasets
por: Wan, Qi, et al.
Publicado: (2020)

Prognostic survival model for people diagnosed with invasive cutaneous melanoma
por: Baade, Peter D, et al.
Publicado: (2015)

The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
por: Fattore, Luigi, et al.
Publicado: (2021)

ERH Interacts With EIF2α and Regulates the EIF2α/ATF4/CHOP Pathway in Bladder Cancer Cells
por: Pang, Kun, et al.
Publicado: (2022)

Lymphatic Transport Efficiency Determines Metastatic Potential of Cutaneous Melanoma
por: Holder, Ashley M., et al.
Publicado: (2020)

Immunometabolic Network Interactions of the Kynurenine Pathway in Cutaneous Malignant Melanoma
por: Rad Pour, Soudabeh, et al.
Publicado: (2020)

Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies
por: Scatena, Cristian, et al.
Publicado: (2021)

Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter
por: Thornton, Jessica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_979cr3netr2om6okv651nek2up